“…Despite these efforts, literature reviews of ethnoracial minority representation in clinical trials for obsessive compulsive disorder (OCD; Williams et al, 2010), panic disorder (Mendoza et al, 2012), depression (Polo et al, 2019), posttraumatic stress disorder (PTSD; Grau et al, 2021), and Prolonged Exposure (PE) therapy for PTSD (Benuto et al, 2020) reveal that ethnoracial minority groups are largely underrepresented in the RCTs that comprise the evidence base for these treatments. Fewer than half of the RCTs for OCD, panic disorder, and depression even reported the ethnoracial characteristics of the samples (Mendoza et al, 2012; Polo et al, 2019; Williams et al, 2010), though there is evidence that reporting practices in clinical trials for depression have improved over time (Polo et al, 2019).…”